ACM
CHE icon

Anfield Capital Management’s Chemed CHE Stock Holding History

Anfield Capital Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-163
Closed -$71K – 89
2022
Q3 		$71K Buy
163
+4
+3% +$1.92K 0.03% 77
2022
Q2 		$75K Buy
159
+53
+50% +$25.9K 0.03% 78
2022
Q1 		$54K Buy
+106
New +$50.8K 0.02% 82
2020
Q1 		– Sell
-226
Closed -$110K – 151
2019
Q4 		$110K Buy
+226
New +$95.1K 0.04% 159

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Anfield Capital Management's CHE Position: Q4 2022 in Review

Anfield Capital Management sold out of Chemed (CHE) in Q4 2022, closing a stake of 163 shares — an estimated $71K sold.

Anfield Capital Management first reported a position in CHE in Q4 2019 and held it in 4 quarters. The position peaked at $110K in Q4 2019. 442 funds tracked by Wall St. Rank hold CHE as of Q4 2022.

  • Anfield Capital Management reported no remaining Chemed position as of Q4 2022 after selling out during the quarter.
  • Anfield Capital Management sold 163 Chemed shares in Q4 2022, an estimated $71K.
  • Anfield Capital Management first reported a position in Chemed in Q4 2019 and held it in 4 quarters.
  • Anfield Capital Management's Chemed position peaked at $110K in Q4 2019.
  • 442 funds tracked by Wall St. Rank held Chemed as of Q4 2022.

Based on Anfield Capital Management's 13F filing for Q4 2022, filed 1 Feb 2023.